welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
terminated
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP)
study id #: NCT00140894
condition: Adenomatous Polyposis Coli
status: terminated
purpose:A study to evaluate rofecoxib in the treatment of rectal, colon, or duodenal adenomas in patients with Familial Adenomatous Polyposis.
intervention:
Drug: MK0966; rofecoxib / Duration of Treatment: 24 weeks
Drug: Comparator: placebo / Duration of Treatment: 24 weeks
study details
study contacts
expertly curated content related to this topic
-
Curcumin in Treating Patients With Familial Adenomatous PolyposisThis clinical trial studies curcumin in ...
-
Laparoscopic Restorative Proctocolectomy: Case-Matched Comparative Study with Open Restorative ProctocolectomyPURPOSE : A laparoscopic approach to res...
-
Global Quantitative Assessment of the Colorectal Polyp Burden in Familial Adenomatous Polyposis by Using a Web-based...BACKGROUND: Accurate measures of the to...
-
Regression of Colonic Adenomas After Treatment with Sulindac in Familial Adenomatous Polyposis: A Case with a 2-Year...Familial adenomatous polyposis (FAP) is ...
-
NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomasInterim results from a randomized clinic...
-
Cell Proliferation and Apoptotic Indices Predict Adenoma Regression in a Placebo-Controlled Trial of Celecoxib in Fa...BACKGROUND : Celecoxib was shown to regr...
-
Guide to Endoscopy of the Ileo-anal Pouch Following Restorative Proctocolectomy with Ileal Pouch-Anal Anastomosis; I...Restorative proctocolectomy (RPC) with i...